Epirus, Ranbaxy win India approval for arthritis drug copy

[riky]

Epirus, Ranbaxy win India approval for arthritis drug copy

<p><a href="http://news.yahoo.com/epirus-ranbaxy-win-india-approval-arthritis-drug-copy-201050052--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/ZjvkDNbLiNWfq97Hcv3mAQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-09-15T201050Z_1_LYNXMPEA8E0XZ_RTROPTP_2_RANBAXY-SETTLEMENT.JPG" width="130" height="86" alt="A Ranbaxy office building is pictured in the northern Indian city of Mohali" align="left" title="A Ranbaxy office building is pictured in the northern Indian city of Mohali" border="0" /></a>By Natalie Grover and Zeba Siddiqui (Reuters) - Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year. The company's Indian partner, Ranbaxy Laboratories Ltd, will sell a copycat version of Johnson &amp; Johnson's and Merck &amp; Co Inc's infliximab, an anti-inflammatory drug with annual sales of about $6 billion. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login